Robert Patrick Friday, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Somatotropin | 1 | 2001 | 76 | 0.190 |
Why?
|
| Autoantigens | 1 | 2002 | 892 | 0.160 |
Why?
|
| Genes, MHC Class I | 1 | 1999 | 258 | 0.160 |
Why?
|
| Genes, MHC Class II | 1 | 1999 | 457 | 0.150 |
Why?
|
| Scleroderma, Diffuse | 1 | 2015 | 17 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 3 | 2002 | 5867 | 0.120 |
Why?
|
| Hydroxychloroquine | 1 | 2018 | 412 | 0.120 |
Why?
|
| Retinal Diseases | 1 | 2018 | 685 | 0.100 |
Why?
|
| 5' Untranslated Regions | 2 | 2002 | 249 | 0.090 |
Why?
|
| Synaptotagmins | 1 | 2010 | 59 | 0.090 |
Why?
|
| Behcet Syndrome | 1 | 2009 | 84 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 1999 | 3338 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2002 | 12066 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2001 | 13028 | 0.070 |
Why?
|
| Biological Therapy | 1 | 2006 | 138 | 0.060 |
Why?
|
| Base Sequence | 4 | 2002 | 12798 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2002 | 18107 | 0.050 |
Why?
|
| Islets of Langerhans | 2 | 1999 | 1350 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2002 | 2050 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4372 | 0.050 |
Why?
|
| Codon, Initiator | 1 | 2001 | 52 | 0.050 |
Why?
|
| Telemedicine | 1 | 2018 | 2874 | 0.050 |
Why?
|
| Disaccharides | 1 | 2001 | 171 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 438 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 514 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2009 | 1558 | 0.040 |
Why?
|
| Exons | 2 | 2002 | 2438 | 0.040 |
Why?
|
| Galactosyltransferases | 1 | 2000 | 264 | 0.040 |
Why?
|
| HLA-DQ Antigens | 1 | 1999 | 210 | 0.040 |
Why?
|
| Cell Movement | 1 | 2010 | 5216 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1999 | 380 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2002 | 2008 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2015 | 1851 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 17439 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 794 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1580 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2327 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2256 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2001 | 1876 | 0.030 |
Why?
|
| Mice | 3 | 2010 | 81154 | 0.030 |
Why?
|
| Scleromyxedema | 1 | 2015 | 8 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6311 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 4737 | 0.030 |
Why?
|
| Hyperpigmentation | 1 | 2015 | 112 | 0.030 |
Why?
|
| Placenta | 1 | 2001 | 1699 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 7719 | 0.020 |
Why?
|
| Pedigree | 1 | 1999 | 4643 | 0.020 |
Why?
|
| Alleles | 2 | 1999 | 6934 | 0.020 |
Why?
|
| Edema | 1 | 2015 | 789 | 0.020 |
Why?
|
| Arthralgia | 1 | 2015 | 456 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1999 | 2037 | 0.020 |
Why?
|
| Synaptotagmin II | 1 | 2010 | 15 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 606 | 0.020 |
Why?
|
| Genital Diseases, Male | 1 | 2009 | 84 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 465 | 0.020 |
Why?
|
| Erythema | 1 | 2009 | 257 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2010 | 607 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12954 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 3794 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 1683 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2009 | 354 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2009 | 533 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2006 | 186 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10940 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2010 | 727 | 0.020 |
Why?
|
| Liver | 1 | 2001 | 7479 | 0.020 |
Why?
|
| Vasculitis | 1 | 2009 | 519 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2015 | 2146 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 26345 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5752 | 0.010 |
Why?
|
| Animals | 5 | 2010 | 168660 | 0.010 |
Why?
|
| Swine | 2 | 2001 | 5909 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 2009 | 880 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6170 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2000 | 209 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1789 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 1619 | 0.010 |
Why?
|
| Humans | 7 | 2018 | 743811 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 991 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 5185 | 0.010 |
Why?
|
| Male | 5 | 2015 | 349776 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 9858 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4152 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2010 | 14563 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 3917 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 1999 | 815 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10179 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 21824 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20121 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6380 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2001 | 4803 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18027 | 0.000 |
Why?
|
| Female | 2 | 2001 | 380020 | 0.000 |
Why?
|
| Aged | 1 | 2015 | 163178 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 35409 | 0.000 |
Why?
|
| Adult | 2 | 2009 | 213889 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1999 | 39001 | 0.000 |
Why?
|
| Mutation | 1 | 1999 | 29777 | 0.000 |
Why?
|